Pharyngeal gonorrhoea: A silent cause for concern

Sexually Transmitted Infections

Volumn 86, Issue 6, 2010, Pages 413-414

  Kinghorn, George ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTIBUTEN; CEFTRIAXONE; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; DYSPHAGIA; EDITORIAL; GONORRHEA; HUMAN; MALE HOMOSEXUAL; ORAL SEXUAL CONTACT; PHARYNGEAL GONORRHEA; PRIORITY JOURNAL; SCREENING; SORE THROAT;

ADOLESCENT; EARLY DIAGNOSIS; FEMALE; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; MALE; PHARYNGEAL DISEASES; PREVALENCE; SEXUAL BEHAVIOR;

EID: 78449255075     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2010.043349     Document Type: Editorial

References (15)

1. Morris SR, Klausner JD, Buchbinder SP, et al. Prevalence and incidence of pharyngeal gonorrhea in a longitudinal sample of men who have sex with men: the EXPLORE study. Clin Infect Dis 2006;43:1284-9.
2. Templeton DJ, Jin F, McNally L, et al. Prevalence, incidence and risk factors for pharyngeal gonorrhoea in a community-based HIV-negative cohort of homosexual men in Sydney, Australia. Sex Transm Infect 2010;86:90-6.
3. Ota KV, Fisman DN, Tamari IE, et al. Incidence and treatment outcomes of pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections in men who have sex with men: a 13-year retrospective cohort study. Clin. Infect Dis 2009;48:1237-43.
4. Wong ML, Chan R, Koh D. Long-term effects of condom promotion programmes for vaginal and oral sex on sexually transmitted infections among sex workers in Singapore. AIDS 2004;18:1195-9.
5. Linhart Y, Shohat T, Amitai Z, et al. Sexually transmitted infections among brothel-based sex workers in Tel-Aviv area, Israel: high prevalence of pharyngeal gonorrhoea. Int J STD AIDS 2008;19:656-9.
6. Centers for Disease Control and Prevention (CDC). Clinic-based testing for rectal and pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections by community-based organizations - five cities, United States, 2007. Morb Mortal Wkly Rep 2009;58:716-19.
7. Bignell C. IUSTI/WHO. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2009;20:453-7.
8. Alexander S. The challenges of detecting gonorrhoea and Chlamydia in rectal and pharyngeal sites: could we, should we, be doing more? Sex Transm Infect 2009;85:159-60.
9. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J Clin Microbiol 2009;47:902-7.
10. Schachter J, Moncada J, Liska S, et al. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008;35:637-42.
11. Ota KV, Tamari IE, Smieja M, et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex Transm Infect 2009;85:182-6.
12. Health Protection Agency. Detection of Neisseria gonorrhoeae using molecular methods. Issue No 1. Issue date: 26.2.10. Issued by: Department of Evaluations, Standards, and Training. QSOP 62i1.
13. de Vries HJ, van der Helm JJ, Schim van der Loeff MF, et al. Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, The Netherlands. Euro Surveill 2009;14:19330.
14. Tapsall J, Read P, Carmody C, et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol 2009;58(Pt 5):683-7.
15. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (grasp) Year 2007 Report. London: Health Protection Agency, 2008.